Mgr. Adriana Ladungová

2023

• CRISPR/Cas9 technology as a useful tool in the study of chornic lymphocytic leukemia.

  PESCHELOVÁ Helena MANČÍKOVÁ Veronika DOSTÁLOVÁ Lenka LADUNGOVÁ Adriana ŠKRNOVÁ Dominika HEJRET Václav ŠMÍDA Michal

  Conference abstract

  Year: 2023, type: Conference abstract

• CRISPR/Cas9 technology as a useful tool in the study of chronic lymphocytic leukemia.

  PESCHELOVÁ Helena KOZLOVÁ Veronika MANČÍKOVÁ Veronika DOSTÁLOVÁ Lenka LADUNGOVÁ Adriana ŠKRNOVÁ Dominika HEJRET Václav ŠMÍDA Michal

  Conference abstract

  Year: 2023, type: Conference abstract

• Exploring the mechanisms of Venetoclax resistence via drug screening and genome-wide CRISPR screening.

  LADUNGOVÁ Adriana PESCHELOVÁ Helena DOSTÁLOVÁ Lenka LODHI Yusuf GOTTUMUKKALA Narendra Varma MAYER Jiří ŠMÍDA Michal

  Conference abstract

  Year: 2023, type: Conference abstract

• Chasing the epigenetic landscape to enhance CAR-T cell activity py preventing CD19 antigen escape in relapsed models.

  GOTTUMUKKALA Narendra Varma LEDEREROVÁ Aneta DOSTÁLOVÁ Lenka LADUNGOVÁ Adriana LODHI Yusuf ŠMÍDA Michal

  Conference abstract

  Year: 2023, type: Conference abstract

2022

• . Drug repurposing for venetoclax-resistant acute myeloid leukemia.

  LADUNGOVÁ Adriana BUŠA Daniel LODHI Yusuf HÝL Jan ČULEN Martin ŠMÍDA Michal

  Conference abstract

  Year: 2022, type: Conference abstract

• Combined drug and CRISPR/CAS9 screening reveals specific targets for SF3B1- and NOTCH1- mutated CLL cells.

  DOSTÁLOVÁ Lenka LADUNGOVÁ Adriana ŠKRNOVÁ Dominika GOTTUMUKKALA Narendra Varma LODHI Yusuf ŠMÍDA Michal

  Conference abstract

  Year: 2022, type: Conference abstract

• Genome-wide Screening Optimizations and High-throughput Compound Screening to Identify Novel Treatment Options in Venetoclax-resistant AML

  LODHI Yusuf LADUNGOVÁ Adriana BUŠA Daniel PESCHELOVÁ Helena ČULEN Martin ŠMÍDA Michal

  Conference abstract

  Year: 2022, type: Conference abstract

• Chasing the epigenetic landscape to enhance CAR-T cell activity by preventing CD19 antigen escape in relapsed models.

  GOTTUMUKKALA Narendra Varma MANČÍKOVÁ Veronika LEDEREROVÁ Aneta KOZLOVÁ Veronika DOSTÁLOVÁ Lenka LADUNGOVÁ Adriana LODHI Yusuf VERNER Jan ŠMÍDA Michal

  Conference abstract

  Year: 2022, type: Conference abstract

• Identification of novel therapeutic options for venetoclax-resistant AML cells through drug repurposing

  LADUNGOVÁ Adriana BUŠA Daniel LODHI Yusuf HÝL Jan ČULEN Martin ŠMÍDA Michal

  Conference abstract

  Year: 2022, type: Conference abstract

• Prediction of novel treatment options for CLL and AML cells based on drug repurposing.

  LADUNGOVÁ Adriana BUŠA Daniel PESCHELOVÁ Helena LODHI Yusuf ČULEN Martin ŠMÍDA Michal

  Conference abstract

  Year: 2022, type: Conference abstract